Frequently asked questions

Participants will need to attend the clinic 15 times over the study. The study includes:

• A screening period of up to 8 weeks, which has 2 clinic visits
• A 24-week treatment period, where participants will need to come in once a fortnight to receive the subcutaneous injections
• A 12-week safety follow-up period which has 1 clinic visit at the end of the study period

[Your answer here...]

[Your answer here...]

[Your answer here...]

[Your answer here...]

[Your answer here...]

[Your answer here...]

[Your answer here...]

[Your answer here...]

[Your answer here...]